Document:

Exhibit

Exhibit 10.29 

November 8, 2017
Ann Lee
Dear Ann,    

Congratulations! On behalf of Juno Therapeutics, Inc., (the “Company” or “Juno”), we are pleased to extend to you an offer to join Juno in the position of EVP, Tech Ops effective as of November 25, 2017 or other mutually agreed upon date (the “Start Date”). This position will be located in Seattle, WA and reports to Hans Bishop, President & Chief Executive Officer.   This position is classified as exempt for purposes of wage and hour law and not subject to federal and state overtime and minimum wage requirements. 

This letter, and its accompanying documents, confirms the terms of the offer.

Salary:

You will be paid a bi-weekly base salary of $19,230.77, which is equivalent to $500,000.00 on an annualized basis, less applicable deductions and withholdings. The salary paid to you covers all hours worked in a workweek. You will be paid your salary in accordance with the Company’s normal payroll practices as established or modified from time to time.
Bonus:
You may be eligible to earn an annual incentive bonus (the “Bonus”) with a target equal to 40% of your annual base salary upon attainment of certain performance objectives during the calendar year to be determined by your manager or the Board of Directors of the Company (the “Board”), which Bonus target may be prorated in the year of hire based on your period of employment. The achievement of such objectives will be determined by your manager or the Board. Your Bonus, if earned, will be payable on or before March 15 following the calendar year in which the Bonus was measured. Any Bonus will not be earned until paid, and you must be employed with the Company at the time of payment to be eligible to receive such payment. Please note that to be eligible for any Bonus for performance during the year you are hired, your Start Date must be prior to October 1 of such year.
Equity Awards:
Subject to the execution and delivery of this letter by you and the Company, the Company will recommend that the Board grant you (i) an option award to purchase 152,900 shares of the Company’s Common Stock (the “Option Award”), (ii) a restricted stock award (the “Time Based RSA Award”) for a number of shares of the Company’s Common Stock equal to $2,200,000 divided by the closing price per share of the Company’s Common Stock on The NASDAQ Global Select Market on your Start Date (or the most recent trading day, if the Start Date is not a trading day), and (iii) a performance restricted stock award (the “Performance RSA Award”) for 35,000 shares of the Company’s Common Stock. The recommended Option Award would vest and become exercisable as to 25% of the shares on the one year anniversary of the Start Date and as to an additional 1/48 of the shares on each subsequent monthly anniversary, subject to your continuing to be a Company service provider through the applicable vesting dates. The recommended Time Based RSA Award would vest as to 50% of the shares on each anniversary of the Start Date over two years, subject to your continuing to be a service provider of the Company through the applicable vesting dates. The recommended Performance RSA Award would vest based on the achievement of certain performance objectives pertaining to the FDA approval of JCAR017 and JCARH125 as set forth in the Performance RSA Award, subject to your continuing to be a service provider of the Company through the applicable vesting dates.
The Option Award, Time Based RSA Award, and Performance RSA Award would each be subject to the terms and conditions of the Company’s 2014 Equity Incentive Plan and an award agreement. The Option Award would have an exercise price per share equal to the fair market value per share of the Company’s Common Stock on the date of the grant of such award, as such fair market value is determined in accordance with the 2014 Equity Incentive Plan. 
Relocation:
To assist with your relocation, the Company will provide you with relocation assistance.  You will receive the Juno Therapeutics Relocation Program for Executives, which includes important relocation, transition, and moving information, along with a relocation tax summary.  Many of the relocation reimbursements advanced to you, or expenses paid on your behalf (collectively, “Relocation Expenses”), may be considered taxable income. For this reason, the Company will provide you tax assistance, also known as gross-up, to reduce certain tax liabilities incurred as a result of your relocation. This tax assistance is not required by law and is not intended to compensate you completely for all tax liabilities. 
The Relocation Expenses will be earned by you if you remain employed by the Company through the second anniversary of your Start Date, and may only be advanced to you if you are an employee of the Company on the date of reimbursement or payment by the Company.  If you resign for any reason or are terminated for reasons related to your performance or conduct on or before the first anniversary of your Start Date, you will not earn and must return 100% of the Relocation Expenses. If you resign for any reason or are terminated for reasons related to your performance or conduct between the first and second anniversaries of your Start Date, you will not earn and must return 50% of the Relocation Expenses. You authorize the Company to deduct any amount owed as an offset against your final paycheck. If the full amount owed is not deducted, you agree to repay the Company within 30 days after termination for any amount still owed, unless the Company agrees to other mutually satisfactory repayment arrangements.
Travel & Accommodation Prior to Relocation:
You understand that even before you relocate to Seattle, you will be expected to work at the Company’s Seattle headquarters, which will be your principal place of employment. You will be reimbursed for up to one round trip between Seattle and the greater San Francisco Bay area per week and for associated ground transportation expenses. Air travel will be reimbursed at coach class fare. The Company also will also provide you with corporate housing in the Seattle area for up to 18 months, not to exceed $6,000 per month. You must submit documentation through our partner Relocation Coordinates International or as otherwise requested by the Company and comply with all applicable company policies. Depending on the circumstances, the travel, transportation, and corporate housing reimbursements to you, or payments by the Company on your behalf, may be considered taxable income. For this reason, for so long as such reimbursements or payments are considered taxable income, the Company will provide you tax assistance, also known as gross-up, to reduce certain tax liabilities incurred in relation to those reimbursements or payments. This tax assistance is not required by law and is not intended to compensate you completely for all tax liabilities.
Change in Control and Severance Benefits:
Subject to you actually commencing employment with Juno, you will be entitled to participate in Juno’s Change in Control and Severance Plan, a copy of which has been provided to you.  In order to participate, you will need to sign and return a participation agreement in the form attached as Appendix A to the Change in Control and Severance Plan, and you will actually have to have commenced employment with Juno.
Section 16 Power of Attorney, Indemnification Agreement:
The Company will recommend to the Board that you be deemed an “executive offer” of the Company within the meaning of Item 401(b) of Regulation S-K under the Securities Act of 1933 and for purposes of Section 16 under the Exchange Act. In such event, you will become subject to Section 16 of the Exchange Act, including reporting requirements for transactions in the Company’s equity securities. In order to enable the Company to assist you with fulfilling such reporting requirements, you will be asked to sign and deliver a Section 16 power of attorney in advance of your Start Date. The Company will also offer you the opportunity to enter into an indemnification agreement with the Company for your benefit, on the Company’s standard form of indemnification agreement for its directors and officers, as filed with the Securities and Exchange Commission.
Other Terms:
Your employment with the Company will be for no specified period and will constitute at‐will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice. We request that you give the Company at least two weeks’ notice if you resign.
You acknowledge and agree that you have disclosed to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. The Company is of the understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. Please notify the Company immediately if this is not accurate. Moreover, you agree that, during the term of your employment with the Company, you will neither engage in any other employment, occupation, consulting, or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment. Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer and, in performing your duties for the Company, you will not in any way use any such information.
As a Company employee, you will be expected to abide by the Company’s rules and standards. Specifically, you will be required to sign an acknowledgment that you have read and understand the policies and guidelines, to include the Company’s rules of conduct, found in the Company’s employee handbook, known as The People Pact. 
You are also required to sign and comply with the accompanying At‐Will Employee Agreement, which requires, among other provisions, the assignment of patent rights to any invention made during your employment at the Company and non‐disclosure of Company proprietary information. In the event of any dispute or claim relating to or arising out of our employment relationship, you and the Company agree that (i) any and all disputes between you and the Company will be fully and finally resolved by binding arbitration, (ii) you are waiving any and all rights to a jury trial but all court remedies will be available in arbitration, (iii) all disputes will be resolved by a neutral arbitrator who will issue a written opinion, and (iv) the Company will pay all the arbitration fees, except an amount equal to the filing fees you would have paid had you filed a complaint in a court of law. 
To accept the terms of employment described in this letter, please sign and date this letter in the space provided below and return it and the signed At-Will Employee Agreement to the Company within three business days of the date appearing at the top of the first page of this letter. If you need additional time to consider this letter and the At-Will Employee Agreement, please ask and we will try to accommodate your request based on the business needs. This letter and the At-Will Employee Agreement set forth the terms of your employment with the Company and supersede any prior representations or agreements, whether written or oral. This letter, including, but not limited to, its at‐will employment provision, may not be modified or amended except by a written agreement signed by (i) the Chief Executive Officer, General Counsel, or SVP, People of the Company and (ii) you. 
This offer and your employment is conditioned on satisfying all conditions of employment, including completion of the At-Will Employee Agreement and this letter, successful completion of a background check, and provision of timely and satisfactory proof of eligibility for U.S. employment. You will separately receive information regarding a background check and the required consent documentation.  
We look forward to working with you at the Company. 
Sincerely, 
/s/ Robin Andrulevich
Robin Andrulevich 
    SVP, People
 
        
Enclosure: At-Will Employee Agreement 

Agreed to and accepted:
Signature:     /s/ Ann L. Lee    
Printed Name:     Ann L. Lee    
Date:  Nov. 9, 2017Exhibit

Exhibit 10.31(E)
FOURTH AMENDMENT TO LEASE AGREEMENT
THIS FOURTH AMENDMENT TO LEASE AGREEMENT (this “Fourth Amendment”) is made as of  November 29 , 2017, by and between ARE-SEATTLE NO. 16, LLC, a Delaware limited liability company (“Landlord”), and JUNO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
RECITALS
A.    Landlord and Tenant are parties to that certain Lease Agreement dated as of April 6, 2015, as amended by that certain First Amendment to Lease Agreement dated as of May 21, 2015 (the “First Amendment”), as further amended by that certain Second Amendment to Lease Agreement dated as of September 30, 2015 (the “Second Amendment”), and as further amended by that certain Third Amendment to Lease Agreement dated as of November 17, 2016 (the “Third Amendment”) (as amended, the “Lease”).  Pursuant to the Lease, Tenant shall lease certain premises containing approximately 241,276 rentable square feet of the Building consisting of (i) the 4th floor containing approximately 33,799 square feet, (ii) the 5th floor containing approximately 26,024 square feet, (iii) the 6th floor containing approximately 26,659 square feet, (iv) the 7th floor containing approximately 26,645 square feet, (v) the 8th floor containing approximately 26,630 square feet, (vi) the 9th floor containing approximately 26,215 square feet, (vii) the 10th floor containing approximately 26,200 square feet, (viii) the 11th floor containing approximately 26,047 square feet, and (ix) the 12th floor containing approximately 23,057 square feet (collectively, the “Premises”) in that certain building located at 400 Dexter Avenue North, Seattle, Washington.  Capitalized terms used herein without definition shall have the meanings defined for such terms in the Lease.
B.    Landlord and Tenant desire as more particularly set forth below in this Fourth Amendment to amend the Lease to, among other things, document that (i) the Fixed Expansion Premises and ROFO Space shall not include the Management Office (as defined below) and (ii) Tenant has 24 months (rather than 12 months) after the Commencement Date to elect to exercise its right under Section 39(a) of the Lease to lease all of available space on the 2nd floor of the Building and as such the Second Expansion Right is no longer necessary and is being deleted.
NOW, THEREFORE, in consideration of the foregoing Recitals, which are incorporated herein by this reference, the mutual promises and conditions contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows:
		
	1.
	Management Office.  Tenant acknowledge and agrees that (i) any Landlord Management Office Parties (as defined below) may lease and/or occupy Suite 200 containing approximately 5,784 rentable square feet on the 2nd floor of the Building in the general location shown on Exhibit A attached hereto (the “Management Office”), (ii) the Fixed Expansion Premises shall not include the Management Office, (iii) ROFO Space shall not include the Management Office, and (iv) the ROFR Space shall not include the Management Office.  Notwithstanding the foregoing, at the point in time when Landlord elects to lease the Management Office to a party unrelated to Landlord and/or its affiliates (and/or any of their respective affiliates, successors and/or assigns) (collectively, “Landlord Management Office Parties”), Landlord shall provide Tenant with advance written notice of Landlord’s election to lease the Management Office space, and Tenant shall have an exclusive period of thirty (30) days in which to elect to lease the Management Office space upon Landlord’s and/or the Landlord Management Office Parties’ vacating said premises.  If Tenant elects to lease the Management Office space by delivery of timely notice to Landlord, said space shall be incorporated into Tenant’s Lease as part of the Premises; however, no allowances or initial free rent periods shall be applicable to the Management Office space, and the Management Office space Base Rent shall be equal, on a per square foot basis, to the highest per square foot rental rate (and shall be subject to the continuing annual Rent Adjustment Percentage increases) paid by Tenant for any portion of its Premises within the Building.

Landlord shall not use the 2nd floor conference facilities or adjoining atrium for public or promotional events (except for Management Office personnel meetings) without the prior consent of Tenant, which consent shall not be unreasonably withheld, conditioned or delayed.  The parties agree that Tenant’s use of such facilities is primary to the use by other tenants and occupants of the Building during Business Hours.  As used in this Fourth Amendment, “Business Hours” shall mean 7:00 a.m. to 6:00 p.m. Monday through Friday (excluding public holidays).  For the avoidance of doubt, Business Hours do not include evenings after 6:00 p.m. Monday through Friday and/or weekends. 
		
	2.
	Right to Expand.  Section 4 of the Third Amendment is hereby deleted in its entirety and replaced with the following:

“The first paragraph of Section 39 of the Lease along with Section 39(a), (b) and (c) of the Lease are all hereby deleted in their entirety and replaced with the following:
“39. Rights to Expand.  Subject to the provisions of this Section 39, Tenant shall have certain rights to expand the Premises to include the Fixed Expansion Premises.  The portion of the 2nd floor (excluding the Management Office) known as Suite 250 containing approximately 4,540  rentable square feet (“Suite 250 Premises”) and the entire rentable square footage available for lease on the 3rd floor containing approximately 20,978 rentable square feet (“3rd Floor Premises”) are collectively referred to herein as the “Fixed Expansion Premises”, and the Suite 250 Premises and the 3rd Floor Premises are individually referred to herein as an “Expansion Floor” and collectively as the “Expansion Floors”.  Tenant is not required to expand the Premises pursuant to Section 39(a) in any particular order (i.e., Tenant can take either the Suite 250 Premises or the 3rd Floor Premises first and then take the other or Tenant may take both premises constituting the Fixed Expansion Premises at the same time). 
(a)    Initial Fixed Expansion Option.  Subject to the terms of this Section 39, Tenant shall have the right (the “Initial Expansion Right”), but not the obligation to expand the Premises for Tenant’s own use (which shall mean that Tenant or the resulting Tenant entity following a Permitted Assignment shall be the initial occupant) to include one or both of the Expansion Floors.  For the avoidance of any doubt, in no event may Tenant elect to exercise its Initial Expansion Right for less than all of the rentable square feet available for lease by Tenant in the Suite 250 Premises and, if applicable, less than the entire 3rd Floor Premises.  If Tenant elects to exercise its Initial Expansion Right with respect to all of the space available for lease by Tenant in the Suite 250 Premises, the 3rd Floor Premises, or both, Tenant shall deliver written notice (each, an “Initial Expansion Election Notice”) to Landlord on or before the date that is 24 months after the Commencement Date (“Initial Option Expiration Date”) identifying whether Tenant is electing to lease all of the Suite 250 Premises, the 3rd Floor Premises or both (as applicable, the “Identified Initial Expansion Premises”).  Up until the Initial Option Expiration Date, Tenant may, subject to the provisions of Section 39, elect to lease all of the available space in the Suite 250 Premises and/or the 3rd Floor Premises, at one time, or pursuant to two separate Initial Expansion Election Notice elections.  Upon the expiration of such 24 month period, the Initial Expansion Right shall expire and Tenant shall have no further options to lease the Fixed Expansion Premises pursuant to the provisions of Section 39(a). If Tenant timely delivers an Initial Expansion Election Notice to Landlord, Tenant shall lease the applicable Identified Initial Expansion Premises on the same terms and conditions pursuant to which Tenant is leasing the Initial Premises, except as otherwise provided in this Section 39(a).  Notwithstanding anything to the contrary contained in this paragraph, Tenant shall have the right, subject to the terms of the Lease, to sublease the Suite 250 Premises from and after the Initial Option Premises Commencement Date without first occupying it. 
If Tenant timely exercises its Initial Expansion Right with respect to one or both Expansion Floors of the Fixed Expansion Premises, Landlord shall Deliver the applicable Identified Initial Expansion Premises to Tenant no later than 10 days after Landlord’s receipt of Tenant’s Initial Expansion Election Notice, with the Building Shell for the applicable Identified Initial Expansion Premises in Tenant Improvement Work Readiness Condition so that Tenant may commence construction of tenant improvements in the applicable Identified Initial Expansion Premises.  The “Initial Option Premises Commencement Date” shall be the date that is the earlier of (x) the date that is 6 months after Landlord Delivers the applicable Identified Initial Expansion Premises to Tenant in Tenant Improvement Work Readiness Condition, and (y) the Substantial Completion of the tenant improvements in the applicable Identified Initial Expansion Premises. On the Initial Option Premises Commencement Date, the Premises shall be expanded to include the applicable Identified Initial Expansion Premises and Tenant shall commence paying Base Rent with respect to the applicable Identified Initial Expansion Premises on a per rentable square foot basis at a rate equal to (A) $54.00 per rentable square foot for the approximately 4,540 rentable square feet in the Suite 250 Premises, and (B) with respect to the 3rd floor if the applicable Identified Initial Expansion Premises includes the 3rd Floor Premises, the then-current Base Rent per rentable square foot being paid with respect to the 4th floor and the 5th floor of the Initial Premises, as adjusted pursuant to Section 4.  If the Initial Premises Base Rent has not commenced on the Initial Option Premises Commencement Date, then Base Rent for the applicable Identified Initial Expansion Premises shall abate until the date that Base Rent is payable with regard to the Initial Premises. If the Initial Option Premises Commencement Date occurs after Base Rent has commenced for the Initial Premises, then Tenant shall not be entitled to any Rent abatement for the applicable Identified Initial Expansion Premises. Furthermore, in the event that Tenant exercises the Initial Expansion Right: (i) the Base Rent payable with respect to the applicable Identified Initial Expansion Premises shall be adjusted on each Adjustment Date by the Rent Adjustment Percentage, (ii) commencing on the Initial Option Premises Commencement Date, the definition of “Tenant’s Share of Operating Expenses” shall be proportionately increased to include the applicable Identified Initial Expansion Space and Tenant shall commence paying Tenant’s Share of Operating Expenses with respect to the applicable Identified Initial Expansion Premises, (iii) with respect to each parking space allocated to Tenant pursuant to Section 10 of the Lease in connection with the applicable Identified Initial Expansion Premises, commencing on the Initial Option Premises Commencement Date, Tenant shall pay Parking Charges equal to the then-current market rate for parking spaces in similar parking garages serving Class A laboratory/office buildings in the South Lake Union area of Seattle, as reasonably determined by Landlord, which Parking Charges shall be subject to increases pursuant to Section 10 of the Lease, and (iv) Tenant shall be entitled to a tenant improvement allowance for tenant improvements in the applicable Identified Initial Expansion Premises in the amount of $145.00 per rentable square foot of the applicable Identified Initial Expansion Premises and the tenant improvements shall be designed and constructed (and the funds for the same disbursed) on substantially similar terms as the Work Letter. Finally, if both the Initial Option Premises Commencement Date shall occur and the applicable Identified Initial Expansion Premises includes the 3rd Floor Premises, then Landlord shall make the Elevator Lobby Allowance and Restroom Allowance in the amount of $50,000 and $200,000, respectively, for the 3rd Floor Premises available to Tenant in consideration for Tenant’s performance of the work associated with said credit, and Exhibit B-1 of the Second Amendment shall be deemed amended accordingly.  Tenant shall not be entitled to any Restroom/Lobby Allowance with respect to the 2nd floor; however, Landlord shall, at Landlord’s expense, complete the build-out of the 2nd floor restrooms, at a quality level consistent with the other restrooms in the Building, no later than December 31, 2017.  The parties shall execute an amendment to this Lease documenting Tenant’s leasing of the applicable Identified Initial Expansion Premises on the terms set forth herein promptly after Tenant delivers to Landlord the Initial Expansion Election Notice.  
(b)    References to the Second Expansion Right in the Lease are hereby deleted in their entirety and shall have no further force or effect.
(c)    References to Third Expansion Right in the Lease are hereby deleted in their entirety and shall have no further force or effect. “
The Fixed Expansion Premises are more particularly shown on Exhibit B attached hereto.
		
	3.
	OFAC.  Tenant and all beneficial owners of Tenant are currently (a) in compliance with and shall at all times during the Term of the Lease remain in compliance with the regulations of the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of Treasury and any statute, executive order, or regulation relating thereto (collectively, the “OFAC Rules”), (b) not listed on, and shall not during the term of the Lease be listed on, the Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List or the Sectoral Sanctions Identifications List, which are all maintained by OFAC and/or on any other similar list maintained by OFAC or other governmental authority pursuant to any authorizing statute, executive order, or regulation, and (c) not a person or entity with whom a U.S. person is prohibited from conducting business under the OFAC Rules.

		
	4.
	Club Corp.  Landlord has entered into a lease agreement with Clubcorp Collective I, LLC, a Nevada limited liability company (“Club Corp”), with respect to certain space on the 1st floor of the Building (“Club Corp Lease”).  Under the Club Corp Lease, (i) Club Corp shall not disturb the occupants of the Project by the use of any radio or musical instrument or by the making of loud or improper noises, (ii) Club Corp shall cause any equipment or machinery to be installed in the Premises so as to reasonably prevent sounds or vibrations from Club Corp’s premises from extending into Common Areas or other space in the Project, and (iii) Club Corp shall not cause or permit any noxious odors to emanate from Club Corp’s premises.  In response to Tenant’s request, Landlord shall not permit Club Corp to use the fitness center or locker room on the 2nd floor of the Building, but nothing contained herein shall preclude Landlord, if it so elects, from retaining an affiliate of Club Corp to provide management services with respect to the fitness center, and Landlord shall restrict Club Corp from using the 2nd floor conference facilities and adjoining atrium during Business Hours without the prior consent of Tenant, which consent shall not be unreasonably withheld, conditioned or delayed.

		
	5.
	Miscellaneous.

a.    This Fourth Amendment is the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous oral and written agreements and discussions between the parties.  This Fourth Amendment may be amended only by an agreement in writing, signed by the parties hereto.
b.    This Fourth Amendment is binding upon and shall inure to the benefit of the parties hereto, and their respective successors and assigns.
c.    This Fourth Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all of which when taken together shall constitute one and the same instrument.  The signature page of any counterpart may be detached therefrom without impairing the legal effect of the signature(s) thereon provided such signature page is attached to any other counterpart identical thereto except having additional signature pages executed by other parties to this Fourth Amendment attached thereto.
d.    Except as amended and/or modified by this Fourth Amendment, the Lease is hereby ratified and confirmed and all other terms of the Lease shall remain in full force and effect, unaltered and unchanged by this Fourth Amendment.  In the event of any conflict between the provisions of this Fourth Amendment and the provisions of the Lease, the provisions of this Fourth Amendment shall prevail.  Whether or not specifically amended by this Fourth Amendment, all of the terms and provisions of the Lease are hereby amended to the extent necessary to give effect to the purpose and intent of this Fourth Amendment.

IN WITNESS WHEREOF, Landlord and Tenant have executed this Fourth Amendment as of the day and year first above written.
TENANT:
JUNO THERAPEUTICS, INC.,
a Delaware corporation
By: /s/ Hans Bishop    
Its: C.E.O.    

LANDLORD:
ARE-SEATTLE NO. 16, LLC,  
a Delaware limited liability company
By:    ALEXANDRIA REAL ESTATE EQUITIES, L.P.,  
    a Delaware limited partnership,  
    managing member
By:    ARE-QRS CORP.,  
         a Maryland corporation,  
         general partner
By: /s/ Gary Dean         
        Its Senior Vice President    
     RE Legal Affairs

LANDLORD’S ACKNOWLEDGMENT

	
	
	A notary public or other officer completing this certificate verifies only the identity of the individual who signed the document to which this certificate is attached, and not the truthfulness, accuracy, or validity of that document.

STATE OF CALIFORNIA         )
 ) §
County of Los Angeles             ) 

On   November 29  , 2017, before me,                RACHEL EARLE                    , a Notary Public, personally appeared                  Gary Dean                                 who proved to me on the basis of satisfactory evidence to be the person(s) whose name(s) is/are subscribed to the within instrument and acknowledged to me that he/she/they executed the same in his/her/their authorized capacity(ies), and that by his/her/their signature(s) on the instrument the person(s), or the entity upon behalf of which the person(s) acted, executed the instrument.

I certify under PENALTY OF PERJURY under the laws of the State of California that the foregoing paragraph is true and correct

WITNESS my hand and official seal.                      [stamp]

 /s/ Rachel Earle            
Signature of Notary                        (Affix seal here)

TENANT’S ACKNOWLEDGMENT

	
		
	STATE OF   WA   

COUNTY OF  King   
	

ss.

On this   28  day of   November , 2017, before me personally appeared        Hans Bishop     , to me known to be the      CEO               of               Juno Therapeutics                 , a _________ _________, that executed the within and foregoing instrument, and acknowledged the said instrument to be the free and voluntary act and deed of said corporation for the uses and purposes therein mentioned, and on oath stated that they were authorized to execute said instrument.
IN WITNESS WHEREOF, I have hereunto set my hand and affixed my official seal the day and year first above written.

 /s/ Patricia Grossbard

(Signature of Notary)

 Patricia Grossbard

(Legibly Print or Stamp Name of Notary)
Notary public in and for the State of  Washington             ,
residing at  400 Dexter Ave N, Seattle, WA 98109    

My appointment expires  5/12/20    

[seal]

Exhibit A
Management Office (Suite 200)

Exhibit B
Fixed Expansion Premises

723403343.4    1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}]]